USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ENDLS OPTICS CORPORATION
Address:
2608 ERWIN RD, STE 148-164
DURHAM, NC 27705-4597
Phone:
N/A
URL:
N/A
EIN:
120511438
DUNS:
781008490
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $440,053.00 2
STTR Phase II $1,169,574.00 1

Award List:

Optical surveillance of tumor margins in patients undergoing breast conserving su

Award Year / Program / Phase:
2007 / STTR / Phase I
Award Amount:
$195,843.00
Agency:
HHS
Principal Investigator:
Research Institution:
DUKE UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): In 2005, 72,000 women that underwent breast surgery had to have a second re-excision surgery due to incomplete removal of the cancer during the first surgery. Needing a second surgery means increased cancer recurrence, patient anxiety, complications, and cost.… More

Fast Spectral Imaging Device For Tumor Margin Mapping

Award Year / Program / Phase:
2009 / STTR / Phase II
Award Amount:
$1,169,574.00
Agency:
HHS
Principal Investigator:
Research Institution:
DUKE UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The American Cancer Society estimates that a total of 240,430 new breast cancers were diagnosed in 2007 (178,400 new cases of invasive breast cancer, and 62,030 new cases of in situ breast cancer). Approximately 180,000 of these patients undergo breast… More

A Quantitative Optical Sensor to Monitor Pre-Clinical Tumor Vascular Physiology

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$244,210.00
Agency:
HHS
Principal Investigator:
Nirmala Ramanujam – 919-660-5307
Research Institution:
DUKE UNIVERSITY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Angiogenesis and hypoxia can significantly influence the efficacy of therapy and the behavior of surviving tumor cells. This important fact is supported by a vast amount of literature on pre-clinical models and clinical studies. There is growing demand for… More